Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

somatropin

somatropin
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Omnitrope POWDER FOR INJECTION, SUBCUTANEOUS 1.5 mg, 5.8 mg      
Zomacton POWDER FOR INJECTION, SUBCUTANEOUS 5 mg, 10 mg      
Norditropin, Omnitrope SOLUTION, SUBCUTANEOUS 5 mg/1.5 mL, 10 mg/1.5 mL, 15 mg/1.5 mL      
Comments:

NORDITROPIN and ACCRETROPIN are classified as non-formulary, not stocked. If needed, the patient should use his/her home supply and initiation should be deferred to the outpatient setting.

OMNITROPE is classified as non-formulary, not stocked. It is indicated for chronic treatment of adults with growth hormone deficiency or children with growth failure due to inadequate secretion of growth hormone. Initiation should be deferred to the outpatient setting. Inpatients may use their own medication in the hospital.

Zomacton is non-formulary, not stocked. Defer initation to outpatient home setting. Inpatients may use their own supply.

Reviewed: August 28, 2008 (OMNITROPE), May 27, 2008 (NORDITROPIN and ACCRETROPIN), and 27 Aug 19 (Zomacton)

Last updated: Aug. 27, 2019






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved